Varicella-Zoster Virus Infection | Argentina| PDF | PPT| Case Reports | Symptoms | Treatment

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Varicella-Zoster Virus Infection

  • Varicella-Zoster Virus Infection

    Pathophysiology: Little is known about the route and the source of transmission of the virus. VZV is certainly transmissible through the airborne route and does not require close personal contact. The skin lesions are certainly full of infectious virus particles whilst in contrast, it is almost impossible to isolate virus from the upper respiratory tract.

  • Varicella-Zoster Virus Infection

    Disease statistics: In Argentina, a country with a variety of climates, including a subtropical climate in the northern region, there is limited data on immunity against VZV in adults in different parts of the country. Additionally, VZV strains circulating in Argentina are unknown.

  • Varicella-Zoster Virus Infection

    Treatment: Several studies indicate that antiviral medications decrease the duration of symptoms and the likelihood of post herpetic neuralgia, especially when initiated within 2 days of the onset of rash. In typical cases that involve individuals who are otherwise healthy, oral acyclovir may be prescribed. An important study by Kubeyinje (1997) suggested that the use of acyclovir in healthy young adults with zoster is not clearly justified, especially in situations of limited economic resources.

  • Varicella-Zoster Virus Infection

    Major Research: Varicella Seroprevalence and Molecular Epidemiology of Varicella-Zoster Virus in Argentina, 2002. The objectives of this study were as follows: (i) to evaluate seroprevalence of varicella in different areas of Argentina, assessing socioeconomic and demographic factors associated with seropositivity and the accuracy of clinical history of the disease; and (ii) to determine the VZV strains circulating in Argentina.

Expert PPTs
Speaker PPTs

High Impact List of Articles

Conference Proceedings